Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
28,000
Employees28,000
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
28,000
Employees28,000

AMGN Key Statistics

Market cap
197.33B
Market cap197.33B
Price-Earnings ratio
25.63
Price-Earnings ratio25.63
Dividend yield
2.61%
Dividend yield2.61%
Average volume
3.46M
Average volume3.46M
High today
$368.48
High today$368.48
Low today
$361.00
Low today$361.00
Open price
$365.05
Open price$365.05
Volume
2.83M
Volume2.83M
52 Week high
$385.12
52 Week high$385.12
52 Week low
$261.43
52 Week low$261.43

Stock Snapshot

With a market cap of 197.33B, Amgen(AMGN) trades at $366.75. The stock has a price-to-earnings ratio of 25.63 and currently yields dividends of 2.6%.

During the trading session on 2026-02-12, Amgen(AMGN) shares reached a daily high of $368.48 and a low of $361.00. At a current price of $366.75, the stock is +1.6% higher than the low and still -0.5% under the high.

Trading volume for Amgen(AMGN) stock has reached 2.83M, versus its average volume of 3.46M.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $385.12 and a low of $261.43.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $385.12 and a low of $261.43.

AMGN News

Nasdaq 16h
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings

Looking at the universe of stocks we cover at Dividend Channel, on 2/13/26, Cencora Inc (Symbol: COR), Amgen Inc (Symbol: AMGN), and Oppenheimer Holdings Inc Cl...

Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings
Simply Wall St 19h
Amgen Is Increasing Its Dividend To $2.52

Amgen Inc.'s ( ) dividend will be increasing from last year's payment of the same period to $2.52 on 6th of March. This makes the dividend yield about the same...

Amgen Is Increasing Its Dividend To $2.52
Nasdaq 2d
Dow Movers: AMGN, DIS

In early trading on Friday, shares of Walt Disney topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.6%. Year to...

Dow Movers: AMGN, DIS

Analyst ratings

50%

of 34 ratings
Buy
44.1%
Hold
50%
Sell
5.9%

More AMGN News

Simply Wall St 2d
Two Days Left Until Amgen Inc. Trades Ex-Dividend

It looks like Amgen Inc. ( ) is about to go ex-dividend in the next two days. The ex-dividend date is usually set to be one business day before the record date,...

Two Days Left Until Amgen Inc. Trades Ex-Dividend
Simply Wall St 4d
Assessing Amgen Valuation After Strong Q4 Earnings And Rising Obesity Drug Optimism

Advertisement Why Amgen’s latest earnings are drawing fresh investor attention Amgen (AMGN) has moved into focus after its Q4 2025 earnings update, which show...

Assessing Amgen Valuation After Strong Q4 Earnings And Rising Obesity Drug Optimism
TipRanks 6d
Amgen Advances Xaluritamig Into Early-Stage Trial for Hard-to-Treat Ewing Sarcoma

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen’s latest clinical update centers on a first‑in‑human Phase 1b study titled “A Phase...

TipRanks 7d
Amgen’s IMLYGIC Safety Study in Melanoma Reaches Completion: What Investors Should Watch

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Study Overview This postmarketing study from Amgen, officially titled “A Postmarketing P...

The Motley Fool 7d
These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys?

Wegovy might be getting more competition soon. During the first half of 2025, Wegovy and Zepbound, two weight loss drugs, ranked among the top 10 best-selling...

These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys?
Simply Wall St 7d
Is Amgen Offering Fair Value After Strong Multi Year Share Price Gains

If you are wondering whether Amgen's current share price gives you fair value for your money, this article will walk through what the numbers say and where valu...

Is Amgen Offering Fair Value After Strong Multi Year Share Price Gains
Nasdaq 7d
Stock Market News for Feb 5, 2026

U.S. stock markets closed mixed on Wednesday as sector rotation by market participants continued. Investors remained concerned about the significantly overstret...

Stock Market News for Feb 5, 2026

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.